High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-09-15
著者
-
CARAVITA Tommaso
Department of Hematology, University "Tor Vergata"
-
SINISCALCHI Agostina
Department of Hematology, University "Tor Vergata"
-
MONTANARO Marco
Department of Hematology, Montefiascone Hospital
-
NISCOLA Pasquale
Department of Hematology, University "Tor Vergata"
-
STASI Roberto
Department of Medical Sciences, Ospedale "Regina Apostolorum"
-
AMADORI Sergio
Department of Hematology, University "Tor Vergata"
-
DE FABRITIIS
Department of Hematology, University "Tor Vergata"
-
De Fabritiis
Haematology Unit "sant'eugenio" Hospital Tor Vergata University
-
De Fabritiis
Department Of Hematology University "tor Vergata
-
Stasi Roberto
Department Of Haematology St. George's Hospital
-
Stasi Roberto
Department Of Medical Sciences Ospedale "regina Apostolorum
-
Amadori Sergio
Department Of Experimental Medicine And Biochemical Sciences University Of Rome "tor Vergata
-
Amadori Sergio
Department Of Hematology University "tor Vergata
-
Montanaro Marco
Department Of Hematology Montefiascone Hospital
-
Caravita Tommaso
Department Of Hematology University "tor Vergata
-
Niscola Pasquale
Division Of Haematology Sant'eugenio Hospital Tor Vergata University
-
Niscola Pasquale
Department Of Hematology University "tor Vergata
-
Siniscalchi Agostina
Department Of Hematology University "tor Vergata
関連論文
- Rapid response and sustained remission by rituximab in four cases of plasma-exchange-failed acute thrombotic thrombocytopenic purpura
- Primary MALT lymphoma of the upper lip mucosa : an exceptionally rare localisation
- High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients
- Deep vein and intracardiac thrombosis during the post-partum period in Behcet's disease
- Pure red cell aplasia associated with hemolytic anemia refractory to standard measures and resolved by rituximab in an elderly patient
- Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) exert their anti-proliferative activity by interfering with Akt-mTOR signaling and bax:bcl-2 ratio modulation in cells from chronic myeloid leukemic patients
- Long term follow-up of a membranous glomerulopathy as late complication of chronic graft-versus-host disease following allogeneic stem cell transplantation
- Bone Marrow Necrosis as a Terminal Complication of a Very Long-Lasting Polycythemia Vera
- Motor disability in the setting of oral anticoagulant therapy
- Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care
- Sleep Complaints in Hospitalized Italian Patients with Hematological Malignancies